1.
Curr Opin Mol Ther
; 6(5): 567-75, 2004 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15537059
RESUMO
PAION GmbH, under license from Schering AG, is developing desmoteplase, a recombinant form of the anticlotting salivary plasminogen activator of the vampire bat Desmodus rotundus (DSPAalpha-1), for the potential treatment of acute ischemic stroke. The drug is currently undergoing phase II clinical trials.